Sildenafil citrate is a selective and potent inhibitor of phosphodiesterase type 5 (PDE5). PDE5 is a cyclic guanosine monophosphate (cGMP) specific degrading enzyme that is highly present in the ...
Methods: This randomised, double blind (DB), placebo controlled, flexible dose study with an open label extension (OLE) assessed efficacy, QoL, and safety of sildenafil citrate in men with MS and ED.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback